Psyence Group Enters into Agreement to Dispose of Stake in PsyLabs [Financial Post (Toronto, Ontario, Canada)]
Psyence Biomedical Ltd. (PBM)
Company Research
Source: Financial Post
PsyLabs develops and produces certified pharmaceutical-grade natural psychedelics for applications in mental health and well-being NEW YORK, Sept. 20, 2024 (GLOBE NEWSWIRE) — Psyence Group Inc (“ Psyence Group ” or the “ Company “) (CSE: PSYG) (as seller), a life science biotechnology company pioneering the use of nature-derived psilocybin in mental health and wellbeing, today announced that it has entered into a conditional share sale agreement with its NASDAQ-listed associate, Psyence Biomedical Ltd. (Nasdaq: PBM) (“ Psyence Biomed ” or “ PBM “) (as purchaser) for the disposal by Psyence Group of its 11.13% stake in privately-held PsyLabs, a company focused on the production of psychedelic active pharmaceutical ingredients (APIs) and extracts for use in research, clinical trials and drug development (“ Proposed Transaction “). Per the terms of the Proposed Transaction, Psyence Biomed will issue to Psyence Group shares of its common stock valued at $1.1 million dollars, at a price
Show less
Read more
Impact Snapshot
Event Time:
PBM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PBM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PBM alerts
High impacting Psyence Biomedical Ltd. news events
Weekly update
A roundup of the hottest topics
PBM
News
- Psyence Group Enters into Agreement to Dispose of Stake in PsyLabs [Yahoo! Finance]Yahoo! Finance
- Psyence Group Enters into Agreement to Dispose of Stake in PsyLabsGlobeNewswire
- Psyence Biomed Enters into Agreement to Acquire Stake in PsyLabsGlobeNewswire
- Psyence Group's NASDAQ-Listed Associate, Psyence Biomed Issues Shareholder Update Recapping Recent Progress and Previewing Key Upcoming Data Milestones [Financial Post (Toronto, Ontario, Canada)]Financial Post
- Psyence Group's NASDAQ-Listed Associate, Psyence Biomed Issues Shareholder Update Recapping Recent Progress and Previewing Key Upcoming Data MilestonesGlobeNewswire
PBM
Sec Filings
- 9/20/24 - Form 6-K
- 9/13/24 - Form 6-K
- 9/5/24 - Form 6-K
- PBM's page on the SEC website